trial · primary record
LY3867070
Healthy
| Phase | Phase 1 |
|---|---|
| Status | COMPLETED |
| Sponsor | Unknown |
| Enrolment | 141 |
| Primary completion | 2026-09-30 |
| Primary endpoint | Number of Participants with One or More Treatment Emergent Adverse Events (TEAEs) Considered by the Investigator to be Related to Study Drug Administration |
| Registry ID | NCT07021547 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-04T03:54:43.346Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07021547
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.